Zyflamend is a trademarked product made by New Chapter. While I normally do not write about a specific product by a specific maker, Zyflamend is a notable product because of the clinical studies using the product on certain cancers. Columbia-Presbyterian Medical Center has tested Zyflamend on early stages of prostate cancer. The results of the first study were published in 2002. They found that Zyflamend doubled the rate at which cancer cells died and led to a 78% reduction in cancer cell numbers after 72 hours. This study was performed only in the laboratory. Clinical studies on humans are currently … Continue reading Cancer Cell Killer?